Chairman & Chief Executive Officer
Avid Biotics

David W. Martin, Jr., M.D., is Chairman and Chief Executive Officer of Avid Biotics. Previously, Dr. Martin was Chairman and CEO of GangaGen, Inc., and he was a founder and CEO of Eos Biotechnology, which merged with Protein Design Labs in April 2003. Previously he has been SVP of R&D at Genentech (1982-1990), Executive VP of R&D at DuPont Merck (1991-1993), and President of Chiron Therapeutics (1994-1995). He currently serves as lead director of the Boards of Varian Medical Systems, Inc., Palo Alto, and Cubist Pharmaceuticals, Inc., Lexington, MA, and he is a member of the California Counsel on Science and Technology and vice-chairman of BayBio. Prior to joining Genentech in 1982, he was Professor of Medicine and Biochemistry at UCSF and Investigator, Howard Hughes Medical Institute.